The pre-series a financing was led by Science Angel Syndicate and Fink Family Office to support pre-clinical studies for the GRACE implant.

Catapult Ventures
Venture CapitalCatapult Ventures is an independent venture capital fund manager that has invested in UK businesses since 2002.
Portfolio
5
companies
Portfolio companies

QV Bioelectronics
QV Bioelectronics builds surgically implanted electric field therapy devices to treat brain tumours.
Monument Therapeutics
Monument Therapeutics develops stratified treatments for central nervous system conditions using digital brain biomarkers.
Healum
Healum develops AI powered patient management software for healthcare professionals.
Pill Connect
Pill Connect builds digital tracking devices to monitor medication adherence in clinical trials.
MyHelp
MyHelp builds digital solutions for mental health service providers and patients.
Team

Emma Johnson
Associate
Emma brings life sciences investment experience from roles at Catapult Ventures and the British Business Bank. She also holds board and observer experience across several therapeutics companies.
Vijay Curthan
Investment Director
Vijay brings investment and private equity experience from roles at Catapult Ventures Group, Magdalene Capital, and QG Investments. He previously held positions at Investment Corporation of Dubai and Oman Investment Authority.
LinkedInRecent investments
Monument Therapeutics secures £2.6m in seed funding led by Catapult Ventures to advance neuroscience drug development.
Catapult Ventures led the seed round alongside Neo Kuma Ventures, Wren Capital, and o2H ventures to support the Cambridge Cognition spinout.
"By establishing Monument Therapeutics, we have created an exciting new venture to develop stratified medicine in CNS drug development that could help many patients with unmet clinical needs. It leverages Cambridge Cognition’s intellectual property and provides the potential for considerable royalty payments in the future, while the Company continues to focus on the development and commercialisation of its cutting-edge digital health technologies."
The digital health company raised the capital to scale its AI powered patient management platform and support remote care programmes.
"Greater Manchester is the only place in the UK that can provide us the data partnerships, research support, diverse population and integrated health and social care practices that will enable us to give healthcare professionals the control and trust in the unbiased intelligence that powers our patient management system."
The funding round was backed by Jonathan Milner, Catapult Ventures and Shallcross Partners to fund regulatory submissions and commercialisation.
Catapult Ventures has backed the Manchester based digital health start-up to fund product trials.
"Healthbox CIC, is really excited to work alongside MyHelp. This new innovative product has huge potential not only to save money to an already overstretched mental health system but will also support people and, as an added bonus, save counsellors’ time."
